ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 10-Q: Q2 2024 Earnings Report
ATAI Life Sciences | 8-K: atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON SABRINA MARTUCCI
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Kalali Amir H
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Fischer Laurent
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Braunstein Scott
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Angermayer Christian
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Director Auerbach Michael
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Fischer Laurent
ATAI Life Sciences | 3: Initial statement of beneficial ownership of securities-Director Braunstein Scott
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-Officer Brand Florian
ATAI Life Sciences | 10-Q: Q1 2024 Earnings Report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 144: Notice of proposed sale of securities pursuant to Rule 144
ATAI Life Sciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ATAI Life Sciences N.V.(65.7%),ATAI Life Sciences AG(65.7%)
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner ATAI Life Sciences N.V.
ATAI Life Sciences | DEF 14A: Definitive information statements
No Data
No Data